Safety Study of GSK Biologicals' Rotavirus Vaccine (Rotarix®) Administered to Children Aged <1 Year in the United States

CompletedOBSERVATIONAL

Enrollment

390,659

Participants

Timeline

Start Date

April 20, 2009

Primary Completion Date

November 4, 2016

Study Completion Date

November 4, 2016

Conditions

Infections, Rotavirus

Interventions

OTHER

Health Insurance Database

Review of two health insurance databases in the US to determine the safety outcomes among infants who have received Rotarix or IPV vaccination.

Trial Locations (1)

GSK Investigational Site, Waltham